{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:48Z","timestamp":1762004808760},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Major Histocompatibility Complex (MHC) or Human Leukocyte Antigen (HLA) Class I molecules bind to peptide fragments of proteins degraded inside the cell and display them on the cell surface. We are interested in peptide-HLA complexes involving peptides that are derived from proteins specifically expressed in cancer cells. Such complexes have been shown to provide an effective means of precisely targeting cancer cells by engineered T-cells and antibodies, which would be an improvement over current chemotherapeutic agents that indiscriminately kill proliferating cells. An important concern with the targeting of peptide-HLA complexes is off-target toxicity that could occur due to the presence of complexes similar to the target complex in cells from essential, normal tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We developed a novel computational strategy for identifying potential peptide-HLA cancer targets and evaluating the likelihood of off-target toxicity associated with these targets. Our strategy combines sequence-based and structure-based approaches in a unique way to predict potential off-targets. The focus of our work is on the complexes involving the most frequent HLA class I allele HLA-A*02:01. Using our strategy, we predicted the off-target toxicity observed in past clinical trials. We employed it to perform a first-ever comprehensive exploration of the human peptidome to identify cancer-specific targets utilizing gene expression data from TCGA (The Cancer Genome Atlas) and GTEx (Gene Tissue Expression), and structural data from PDB (Protein Data Bank). We have thus identified a list of 627 peptide-HLA complexes across various TCGA cancer types.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Peptide-HLA complexes identified using our novel strategy could enable discovery of cancer-specific targets for engineered T-cells or antibody based therapy with minimal off-target toxicity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-016-1150-2","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T13:34:46Z","timestamp":1469021686000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy"],"prefix":"10.1186","volume":"17","author":[{"given":"Ankur","family":"Dhanik","sequence":"first","affiliation":[]},{"given":"Jessica","family":"R. Kirshner","sequence":"additional","affiliation":[]},{"given":"Douglas","family":"MacDonald","sequence":"additional","affiliation":[]},{"given":"Gavin","family":"Thurston","sequence":"additional","affiliation":[]},{"given":"Hsin","family":"C. Lin","sequence":"additional","affiliation":[]},{"given":"Andrew","family":"J. Murphy","sequence":"additional","affiliation":[]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"issue":"12","key":"1150_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nri1250","volume":"3","author":"JW Yewdell","year":"2003","unstructured":"Yewdell JW, Reits E, Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol. 2003; 3(12):952\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1150_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1568010043483881","volume":"3","author":"C Monaco","year":"2004","unstructured":"Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets-Inflammation Allergy. 2004; 3(1):35\u201342.","journal-title":"Curr Drug Targets-Inflammation Allergy"},{"issue":"3","key":"1150_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0161-5890(02)00098-6","volume":"39","author":"AL Goldberg","year":"2002","unstructured":"Goldberg AL, Cascio P, Saric T, Rock KL. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol. 2002; 39(3):147\u201364.","journal-title":"Mol Immunol"},{"issue":"12","key":"1150_CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of mhc class i and mhc class ii antigen presentation. Nat Rev Immunol. 2011; 11(12):823\u201336.","journal-title":"Nat Rev Immunol"},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0065-2776(09)01202-4","volume":"102","author":"H Jiang","year":"2009","unstructured":"Jiang H, Chess L. How the immune system achieves self\u2013nonself discrimination during adaptive immunity. Adv Immunol. 2009; 102:95\u2013133.","journal-title":"Adv Immunol"},{"issue":"6","key":"1150_CR6","first-page":"267","volume":"11","author":"UH Weidle","year":"2014","unstructured":"Weidle UH, Georges G, Tiefenthaler G. Tcr-mhc\/peptide interaction: prospects for new anti-tumoral agents. Cancer Genomics-Proteomics. 2014; 11(6):267\u201377.","journal-title":"Cancer Genomics-Proteomics"},{"issue":"6","key":"1150_CR7","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.4049\/jimmunol.177.6.4187","volume":"177","author":"VP Wittman","year":"2006","unstructured":"Wittman VP, Woodburn D, Nguyen T, Neethling FA, Wright S, Weidanz JA. Antibody targeting to a class i mhc-peptide epitope promotes tumor cell death. J Immunol. 2006; 177(6):4187\u201395.","journal-title":"J Immunol"},{"issue":"95","key":"1150_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/scitranslmed.3002842","volume":"3","author":"M Kalos","year":"2011","unstructured":"Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011; 3(95):95\u201373.","journal-title":"Sci Transl Med"},{"issue":"11","key":"1150_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.tibtech.2011.04.009","volume":"29","author":"TS Park","year":"2011","unstructured":"Park TS, Rosenberg SA, Morgan RA. Treating cancer with genetically engineered t cells. Trends Biotechnol. 2011; 29(11):550\u20137.","journal-title":"Trends Biotechnol"},{"issue":"16","key":"1150_CR10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, et al.Chimeric antigen receptor\u2013modified t cells for acute lymphoid leukemia. N Engl J Med. 2013; 368(16):1509\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"1150_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nbt.2459","volume":"31","author":"CC Kloss","year":"2013","unstructured":"Kloss CC, Condomines M, Cartellieri M, Bachmann M, Sadelain M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered t cells. Nat Biotechnol. 2013; 31(1):71\u20135.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"1150_CR12","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1158\/0008-5472.CAN-09-0547","volume":"69","author":"PA Baeuerle","year":"2009","unstructured":"Baeuerle PA, Reinhardt C. Bispecific t-cell engaging antibodies for cancer therapy. Cancer Res. 2009; 69(12):4941\u2013944.","journal-title":"Cancer Res"},{"issue":"6","key":"1150_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4161\/mabs.1.6.10015","volume":"1","author":"P Chames","year":"2009","unstructured":"Chames P, Baty D. Bispecific antibodies for cancer therapy: the light at the end of the tunnel?mAbs. 2009; 1(6):539\u2013547.","journal-title":"mAbs"},{"issue":"3","key":"1150_CR14","first-page":"340","volume":"12","author":"A Thakur","year":"2010","unstructured":"Thakur A, Lum LG. Cancer therapy with bispecific antibodies: Clinical experience. Curr Opin Mol Ther. 2010; 12(3):340.","journal-title":"Curr Opin Mol Ther"},{"issue":"2","key":"1150_CR15","doi-asserted-by":"publisher","first-page":"e22891","DOI":"10.4161\/onci.22891","volume":"2","author":"J Oates","year":"2013","unstructured":"Oates J, Jakobsen BK. ImmTACs: Novel bi-specific agents for targeted cancer therapy. Oncoimmunology. 2013; 2(2):e22891.","journal-title":"Oncoimmunology"},{"issue":"5","key":"1150_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrclinonc.2013.46","volume":"10","author":"JN Kochenderfer","year":"2013","unstructured":"Kochenderfer JN, Rosenberg SA. Treating b-cell cancer with t cells expressing anti-cd19 chimeric antigen receptors. Nat Rev Clin Oncol. 2013; 10(5):267\u201376.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1150_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","volume":"36","author":"RA Morgan","year":"2013","unstructured":"Morgan RA, Chinnasamy N, Abate-Daga DD, Gros A, Robbins PF, Zheng Z, Feldman SA, Yang JC, Sherry RM, Phan GQ, et al.Cancer regression and neurologic toxicity following anti-mage-a3 tcr gene therapy. J Immunother. 2013; 36(2):133.","journal-title":"J Immunother"},{"issue":"1","key":"1150_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2013.09.016","volume":"352","author":"L Wayteck","year":"2014","unstructured":"Wayteck L, Breckpot K, Demeester J, De Smedt SC, Raemdonck K. A personalized view on cancer immunotherapy. Cancer Lett. 2014; 352(1):113\u201325.","journal-title":"Cancer Lett"},{"issue":"11","key":"1150_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nbt.2725","volume":"31","author":"CS Hinrichs","year":"2013","unstructured":"Hinrichs CS, Restifo NP. Reassessing target antigens for adoptive t-cell therapy. Nat Biotechnol. 2013; 31(11):999\u20131008.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1150_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0247-y","volume":"7","author":"RA Holt","year":"2015","unstructured":"Holt RA. Immunogenomics: a foundation for intelligent immune design. Genome Med. 2015; 7(1):1\u20133.","journal-title":"Genome Med"},{"issue":"4","key":"1150_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of t cells transduced with a chimeric antigen receptor recognizing erbb2. Mol Therapy. 2010; 18(4):843\u201351.","journal-title":"Mol Therapy"},{"issue":"197","key":"1150_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/scitranslmed.3006034","volume":"5","author":"BJ Cameron","year":"2013","unstructured":"Cameron BJ, Gerry AB, Dukes J, Harper JV, Kannan V, Bianchi FC, Grand F, Brewer JE, Gupta M, Plesa G, et al.Identification of a titin-derived hla-a1\u2013presented peptide as a cross-reactive target for engineered mage a3\u2013directed t cells. Sci Transl Med. 2013; 5(197):197\u201303.","journal-title":"Sci Transl Med"},{"issue":"6","key":"1150_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","volume":"122","author":"GP Linette","year":"2013","unstructured":"Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, et al.Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced t cells in myeloma and melanoma. Blood. 2013; 122(6):863\u201371.","journal-title":"Blood"},{"issue":"2","key":"1150_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1440-1711.2001.00994.x","volume":"79","author":"M Regner","year":"2001","unstructured":"Regner M. Cross-reactivity in t-cell antigen recognition. Immunol Cell Biol. 2001; 79(2):91\u2013100.","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"1150_CR25","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.4049\/jimmunol.1500233","volume":"194","author":"MJ Rist","year":"2015","unstructured":"Rist MJ, Hibbert KM, Croft NP, Smith C, Neller MA, Burrows JM, Miles JJ, Purcell AW, Rossjohn J, Gras S, Burrows SR. T cell cross-reactivity between a highly immunogenic ebv epitope and a self-peptide naturally presented by hla-b*18:01 + cells. J Immunol. 2015; 194(10):4668\u2013675.","journal-title":"J Immunol"},{"issue":"11","key":"1150_CR26","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/bioinformatics\/btv068","volume":"31","author":"K Haase","year":"2015","unstructured":"Haase K, Raffegerst S, Schendel DJ, Frishman D. Expitope: a web server for epitope expression. Bioinformatics. 2015; 31(11):1854\u20136.","journal-title":"Bioinformatics"},{"issue":"9","key":"1150_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.humimm.2007.04.005","volume":"68","author":"M Maiers","year":"2007","unstructured":"Maiers M, Gragert L, Klitz W. High-resolution hla alleles and haplotypes in the united states population. Hum Immunol. 2007; 68(9):779\u201388.","journal-title":"Hum Immunol"},{"issue":"6","key":"1150_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1371\/journal.pcbi.0020065","volume":"2","author":"B Peters","year":"2006","unstructured":"Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, Kostem E, Basch D, Lamberth K, Harndahl M, Fleri W, et al.A community resource benchmarking predictions of peptide binding to mhc-i molecules. PLoS Comput Biol. 2006; 2(6):65.","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"1150_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1371\/journal.pone.0000796","volume":"2","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, R\u00f8der G, Peters B, Sette A, Lund O, et al.Netmhcpan, a method for quantitative predictions of peptide binding to any hla-a and-b locus protein of known sequence. PloS ONE. 2007; 2(8):796.","journal-title":"PloS ONE"},{"issue":"1","key":"1150_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-90","volume":"11","author":"K Roomp","year":"2010","unstructured":"Roomp K, Antes I, Lengauer T. Predicting mhc class i epitopes in large datasets. BMC Bioinformatics. 2010; 11(1):1.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"1150_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/imm.12160","volume":"141","author":"KW J\u00f8rgensen","year":"2014","unstructured":"J\u00f8rgensen KW, Rasmussen M, Buus S, Nielsen M. Netmhcstab\u2013predicting stability of peptide\u2013mhc-i complexes; impacts for cytotoxic t lymphocyte epitope discovery. Immunology. 2014; 141(1):18\u201326.","journal-title":"Immunology"},{"issue":"6","key":"1150_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, et al.The genotype-tissue expression (gtex) project. Nat Genet. 2013; 45(6):580\u20135.","journal-title":"Nat Genet"},{"key":"1150_CR33","doi-asserted-by":"publisher","first-page":"bar009","DOI":"10.1093\/database\/bar009","volume":"2011","author":"M Magrane","year":"2011","unstructured":"Magrane M, UniProt Consortium, et al.Uniprot knowledgebase: a hub of integrated protein data. Database. 2011; 2011:bar009.","journal-title":"Database"},{"issue":"7235","key":"1150_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature07672","volume":"458","author":"M Guttman","year":"2009","unstructured":"Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al.Chromatin signature reveals over a thousand highly conserved large non-coding rnas in mammals. Nature. 2009; 458(7235):223\u20137.","journal-title":"Nature"},{"issue":"suppl 1","key":"1150_CR35","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/nar\/gkp1004","volume":"38","author":"R Vita","year":"2010","unstructured":"Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res. 2010; 38(suppl 1):854\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1150_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M. Rna-seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009; 10(1):57\u201363.","journal-title":"Nat Rev Genet"},{"issue":"14","key":"1150_CR37","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/bioinformatics\/bts294","volume":"28","author":"J Hu","year":"2012","unstructured":"Hu J, Ge H, Newman M, Liu K. Osa: a fast and accurate alignment tool for rna-seq. Bioinformatics. 2012; 28(14):1933\u20134.","journal-title":"Bioinformatics"},{"issue":"7","key":"1150_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by rna-seq. Nat Methods. 2008; 5(7):621\u20138.","journal-title":"Nat Methods"},{"issue":"17","key":"1150_CR39","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1073\/pnas.1318948111","volume":"111","author":"M Kellis","year":"2014","unstructured":"Kellis M, Wold B, Snyder MP, Bernstein BE, Kundaje A, Marinov GK, Ward LD, Birney E, Crawford GE, Dekker J, et al.Defining functional dna elements in the human genome. Proc Natl Acad Sci. 2014; 111(17):6131\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1150_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/j.1538-7305.1950.tb00463.x","volume":"29","author":"RW Hamming","year":"1950","unstructured":"Hamming RW. Error detecting and error correcting codes. Bell Syst Technical J. 1950; 29(2):147\u201360.","journal-title":"Bell Syst Technical J"},{"key":"1150_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","volume":"24","author":"MG Rudolph","year":"2006","unstructured":"Rudolph MG, Stanfield RL, Wilson IA. How tcrs bind mhcs, peptides, and coreceptors. Annu Rev Immunol. 2006; 24:419\u201366.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"1150_CR42","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/prot.23104","volume":"79","author":"MA Cuendet","year":"2011","unstructured":"Cuendet MA, Zoete V, Michielin O. How t cell receptors interact with peptide-mhcs: A multiple steered molecular dynamics study. Proteins Struct Funct Bioinformatics. 2011; 79(11):3007\u201324.","journal-title":"Proteins Struct Funct Bioinformatics"},{"issue":"1","key":"1150_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000; 28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"1150_CR44","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. Ucsf chimera-a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605\u201312.","journal-title":"J Comput Chem"},{"key":"1150_CR45","volume-title":"Encyclopedia of database systems","author":"P Refaeilzadeh","year":"2009","unstructured":"Refaeilzadeh P, Tang L, Liu H. Cross-validation. In: Encyclopedia of database systems. Boston, MA: Springer: 2009. p. 532\u2013538."},{"issue":"5","key":"1150_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","volume":"157","author":"ME Birnbaum","year":"2014","unstructured":"Birnbaum ME, Mendoza JL, Sethi DK, Dong S, Glanville J, Dobbins J, \u00d6zkan E, Davis MM, Wucherpfennig KW, Garcia KC. Deconstructing the peptide-mhc specificity of t cell recognition. Cell. 2014; 157(5):1073\u201387.","journal-title":"Cell"},{"issue":"5796","key":"1150_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.1129003","volume":"314","author":"RA Morgan","year":"2006","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, et al.Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006; 314(5796):126\u20139.","journal-title":"Science"},{"issue":"2","key":"1150_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/joim.12020","volume":"273","author":"M Essand","year":"2013","unstructured":"Essand M, Loskog AS. Genetically engineered t cells for the treatment of cancer. J Intern Med. 2013; 273(2):166\u201381.","journal-title":"J Intern Med"},{"key":"1150_CR49","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1200\/JCO.2011.40.2271","volume":"30","author":"B Weide","year":"2012","unstructured":"Weide B, Zelba H, Derhovanessian E, Pflugfelder A, Eigentler TK, Di Giacomo AM, Maio M, Aarntzen EH, de Vries IJM, Sucker A, et al.Functional t cells targeting ny-eso-1 or melan-a are predictive for survival of patients with distant melanoma metastasis. J Clin Oncol. 2012; 30:1835\u20131841.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1150_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4049\/jimmunol.1001775","volume":"186","author":"N Chinnasamy","year":"2011","unstructured":"Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, et al.A tcr targeting the hla-a* 0201\u2013restricted epitope of mage-a3 recognizes multiple epitopes of the mage-a antigen superfamily in several types of cancer. J Immunol. 2011; 186(2):685\u201396.","journal-title":"J Immunol"},{"key":"1150_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(06)95001-5","volume":"95","author":"S Gnjatic","year":"2006","unstructured":"Gnjatic S, Nishikawa H, Jungbluth AA, G\u00fcre AO, Ritter G, J\u00e4ger E, Knuth A, Chen YT, Old LJ. Ny-eso-1: Review of an immunogenic tumor antigen. Adv Cancer Res. 2006; 95:1\u201330.","journal-title":"Adv Cancer Res"},{"issue":"7","key":"1150_CR52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, et al.Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with ny-eso-1. J Clin Oncol. 2011; 29(7):917\u201324.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1150_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00018-005-5462-z","volume":"63","author":"J Koch","year":"2006","unstructured":"Koch J, Tampe R. The macromolecular peptide-loading complex in mhc class i-dependent antigen presentation. Cell Mol Life Sci. 2006; 63(6):653\u201362.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"1150_CR54","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/intimm\/dxg084","volume":"15","author":"P Saxov\u00e1","year":"2003","unstructured":"Saxov\u00e1 P, Buus S, Brunak S, Ke\u015fmir C. Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol. 2003; 15(7):781\u20137.","journal-title":"Int Immunol"},{"issue":"4","key":"1150_CR55","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","volume":"171","author":"B Peters","year":"2003","unstructured":"Peters B, Bulik S, Tampe R, Van Endert PM, Holzh\u00fctter HG. Identifying mhc class i epitopes by predicting the tap transport efficiency of epitope precursors. J Immunol. 2003; 171(4):1741\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"1150_CR56","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1110\/ps.03373104","volume":"13","author":"M Bhasin","year":"2004","unstructured":"Bhasin M, Raghava G. Analysis and prediction of affinity of tap binding peptides using cascade svm. Protein Sci. 2004; 13(3):596\u2013607.","journal-title":"Protein Sci"},{"issue":"3","key":"1150_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/0008-5472.CAN-03-2209","volume":"64","author":"KT Hogan","year":"2004","unstructured":"Hogan KT, Coppola MA, Gatlin CL, Thompson LW, Shabanowitz J, Hunt DF, Engelhard VH, Ross MM, Slingluff CL. Identification of novel and widely expressed cancer\/testis gene isoforms that elicit spontaneous cytotoxic t-lymphocyte reactivity to melanoma. Cancer Res. 2004; 64(3):1157\u201363.","journal-title":"Cancer Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1150-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-016-1150-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1150-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1150-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:58:59Z","timestamp":1706810339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1150-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1150-2","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"286"}}